Project 4, Dweik) Hyaluronan in Pulmonary Hypertension - Idiopathic pulmonary arterial hypertension (IPAH) is a progressive disease that leads to deterioration in cardiopulmonary function and premature death from right ventricular failure. The pathogenesis of IPAH is not fully understood. Although pulmonary artery smooth muscle cells (PASMCs) are considered a major component of the remodeling process in IPAH, the nature of the primary abnormality that triggers and perpetuates PASMC proliferation in IPAH is unclear. We have recently discovered and reported the novel finding that PASMCs from IPAH lungs spontaneously produce high levels of hyaluronan (HA) and that IPAH patients have higher than normal levels of circulating HA in their blood. We hypothesize that abnormalities in HA amount, modification, and fragmentation result in major regulatory switches directing abnormal smooth muscle cell proliferation, inflammation and vascular remodeling in IPAH.
Our specific aims are designed to assess the mechanisms of increased HA production and the regulatory role(s) HA has in perpetuating PASMC proliferation, inflammation, and vascular remodeling in IPAH.
Specific Aim 1 : Define the mechanism(s) regulating HA production in PASMCs in IPAH. We will evaluate the expression of the different Has and Hyal mRNAs and proteins from PASMCs isolated from lungs of IPAH patients and controls, as well as for smooth muscle cells (SMCs) from other sources, and for other cell types to ascertain the uniqueness of the PASMCs. We will also determine if there are genetic or epigenetic abnormalities regulating HA production in these cells.
Specific Aim 2 : Determine the role(s) of HA in IPAH. We will accomplish this Aim by studying the functional consequences of the high levels of HA in vascular SMC proliferation and inflammation in IPAH in vivo and ex vivo. We will also correlate HA levels with disease outcomes in patients with IPAH.
Specific Aim 3 : Uncover the mechanlsm(s) responsible for the proliferative and pro-inflammatory functions of HA in IPAH. We will study this by evaluating the specific HA modification(s) that turn this primarily structural molecule under normal physiological conditions into a molecule that stimulates cell proliferation and inflammation in the IPAH lung.

Public Health Relevance

While it is currently recognized that cell proliferation and vascular remodeling are very important processes in the pathogenesis of IPAH, they remain poorly understood. The work proposed here will have a major impact not only on our understanding of the pathobiology of remodeling and cell proliferation in IPAH, but also on the development of better ways to diagnose, monitor and ultimately treat/cure IPAH.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL107147-03
Application #
8494082
Study Section
Special Emphasis Panel (ZHL1-CSR-H)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
3
Fiscal Year
2013
Total Cost
$343,251
Indirect Cost
$124,193
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Kim, Yeojung; West, Gail A; Ray, Greeshma et al. (2017) Layilin is critical for mediating hyaluronan 35kDa-induced intestinal epithelial tight junction protein ZO-1 in vitro and in vivo. Matrix Biol :
Kessler, Sean P; Obery, Dana R; Nickerson, Kourtney P et al. (2017) Multifunctional Role of 35 Kilodalton Hyaluronan in Promoting Defense of the Intestinal Epithelium. J Histochem Cytochem :22155417746775
Saikia, Paramananda; Bellos, Damien; McMullen, Megan R et al. (2017) MicroRNA 181b-3p and its target importin ?5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol. Hepatology 66:602-615
Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Emond, Audrey et al. (2017) The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity. Elife 6:
Ghatak, Shibnath; Markwald, Roger R; Hascall, Vincent C et al. (2017) Transforming growth factor ?1 (TGF?1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. J Biol Chem 292:10465-10489
Petrey, Aaron C; de la Motte, Carol A (2017) The extracellular matrix in IBD: a dynamic mediator of inflammation. Curr Opin Gastroenterol 33:234-238
Ghatak, Shibnath; Hascall, Vincent C; Markwald, Roger R et al. (2017) Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem 292:10490-10519
Asano, Keiichi; Nelson, Courtney M; Nandadasa, Sumeda et al. (2017) Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis. Sci Rep 7:17225
Hendee, Kathryn; Wang, Lauren Weiping; Reis, Linda M et al. (2017) Identification and functional analysis of an ADAMTSL1 variant associated with a complex phenotype including congenital glaucoma, craniofacial, and other systemic features in a three-generation human pedigree. Hum Mutat 38:1485-1490
Stober, Vandy P; Johnson, Collin G; Majors, Alana et al. (2017) TNF-stimulated gene 6 promotes formation of hyaluronan-inter-?-inhibitor heavy chain complexes necessary for ozone-induced airway hyperresponsiveness. J Biol Chem 292:20845-20858

Showing the most recent 10 out of 109 publications